Green boenning scattergood weighs seritage growth properties earnings srg

Related Stories:

Living

Green

boenning scattergood weighs seritage growth properties earnings srg

raging river exploration inc post earnings per share beacon securities forecasts rrx

nisa investment advisors llc decreases position neustar inc nsr

eps estimates sun life financial inc slf decreased analyst

national bank financial equities analysts boost earnings estimates franco nevada corp fnv

dun bradstreet corp dnb updates fy earnings guidance

zillow group inc zg price target raised benchmark

nisa investment advisors llc sells shares synnex snx

crocs inc crox trading higher earnings beat

meredith mdp stake held state alaska department revenue

Green Sun May 21 2017 15:18:34 GMT+0000 (UTC)
WHERE THE PARTY'S AT -- Seritage Growth Properties (NYSE:SRG) – Equities research analysts at Boenning Scattergood increased their Q2 2017 EPS estimates for shares of Seritage Growth Properties in a report released on Tuesday. Boenning Scattergood analyst F. Van.
Wall Street brokerages expect Heico Corp (NYSE:HEI) to announce earnings per share (EPS) of $0.50 for the current quarter, Zacks reports. Two analysts have provided estimates for Heico Corp’s earnings, with the lowest EPS estimate coming in
Digital Turbine Inc (NASDAQ:APPS) saw a significant growth in short interest in April. As of April 13th, there was short interest totalling 2,759,049 shares, a growth of 1.0% from the March 31st total of 2,732,662 shares. Based on an average trading
Interfor Corp (TSE:IFP) – National Bank Financial increased their Q2 2017 earnings estimates for shares of Interfor Corp in a report released on Sunday. National Bank Financial analyst R. Merer now expects that the company will post earning
Farmland Partners Inc (NYSE:FPI) – Equities researchers at FBR & Co cut their Q2 2017 earnings estimates for Farmland Partners in a report issued on Wednesday. FBR & Co analyst J. Levi-Ribner now forecasts that the financi
Eagle Pharmaceuticals Inc (NASDAQ:EGRX) – Equities researchers at William Blair decreased their Q2 2017 earnings per share estimates for Eagle Pharmaceuticals in a report released on Monday. William Blair analyst T. Lugo now anticipates tha
Wall Street analysts expect Waddell & Reed Financial, Inc. (NYSE:WDR) to announce earnings per share (EPS) of $0.39 for the current quarter, according to Zacks Investment Research. Three analysts have made estimates for Waddell & Re
Wall Street brokerages predict that STMicroelectronics NV (NYSE:STM) will post earnings of $0.18 per share for the current fiscal quarter, according to Zacks Investment Research. Three analysts have provided estimates for STMicroelectronics NV&#8